Cite Filings / DNLI / 0001628280-22-026571

Feed Companies Filings Check

Sign in

424B5

Prospectus

Denali Therapeutics Inc. Filed 2022-10-18 Acc 0001628280-22-026571

Documents 1

424B5 Prospectus , denaliprosupp424b5prelim.htm

Around this filing

2022-10-20 8-K Material agreement · Other events
2022-10-20 424B5 Prospectus
2022-10-18 8-K Results of operations · Other events
2022-10-18 424B5 Prospectus
2022-10-12 4 COFO and Secretary acquired 20,000 shares (option exercise)
2020-01-29 424B5 Prospectus

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading denaliprosupp424b5prelim.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…